Dr. Rohit Gutgutia - Life Conference 2016
Dr. Rohit Gutgutia talks about Current and future status of Ovulation Induction in PCOS at Life Conference 2016. For more information visit ...
IIRRH Institute
Anastrozole duration for post-menopausal breast cancer patients after 5 years of endocrine therapy
Prof Michael Gnant speaks with ecancer at SABCS 2017 to discuss the outcomes of a multi-centre phase III randomised trial of 2 or 5 years of anastrozole for ...
ecancer
Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, et alt.
Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, et alt. A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 ...
Oncoletter
EULAR 2019 - Press conference: Loss prevention of bone mineral density in post-menopausal women
The results of a study presented at the Annual European Congress of Rheumatology (EULAR 2019) finds the risk of bone mineral density (BMD) loss after ...
EULAR - European League against Rheumatism
Combining chemotherapy and hormone therapy for the treatment of luminal metastatic breast cancer
Prof Hesham El-Ghazaly speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the combination of chemotherapy and hormone therapy for the ...
ecancer
Lessons from the Global Consensus on Testosterone for Women
Lessons from the Global Consensus on Testosterone for Women This presentation will discuss why, when and how to prescribe testosterone for women and ...
International Menopause Society
Low dose exemestane usage in breast cancer
Dr Serrano talks with ecancer at The Umberto Veronesi Milan Breast Cancer Conference about breast cancer prevention techniques and his aim to reduce the ...
ecancer
?????? ?? ???? ??́?????????? - Dr Suzette Delaloge
Réunion-débat d'information sur "Cancer du sein métastatique : traitements et perspectives" organisée par l'Espace de Rencontres ...
Informations Cancer du Sein
The OncoAlert Colloquium Day 3 (Breast Cancer)
Todays presentations are The best of 2020 in Breast Cancer Dr. Erika Hamilton of Sarah Cannon Cancer Institute, Advanced Hormone receptor positive HER2 ...
OncoAlert 360
MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer
Dr Di Leo presents in a press conference at the ESMO 2017 Congress in Madrid data from the MONARCH 3 trail looking at abemaciclib as initial therapy for ...
ecancer
Two years of extended anastrazole therapy as effective as five
Prof Gnant speaks at a SABCS 2017 press session about data from the ABCSG-16 phase III trial. Postmenopausal women with hormone-receptor positive ...
ecancer
Aging - ENDO 2019 Press Conference
The Society debuted a new Clinical Practice Guideline for treating osteoporosis in postmenopausal women. Researchers also covered older men with higher ...
The Endocrine Society
2017 Oncofertility Conference: Stacy Lindau, MD
Preservation of Sexual Function Among Women Affected by Cancer.
Oncofertility Consortium
Dr. Shir Dar, Israel - Life Conference 2016
Dr. Shir Dar, Israel talks about Mild Ovarian Stimulation (IVF Lite) at Life Conference 2016. For more information visit http://lifeconference.in.
IIRRH Institute
Traitement anti hormonal et nutrition - Carole Kalogeropoulos
Mme Carole Kalogeropoulos, diététicienne-nutritionniste à l'Institut Curie explique l'importance de la gestion de l'alimentation lors d'un traitement par ...
Institut Curie
Melinda L. Irwin: Randomized trial of exercise vs. usual care on aromatase inhibitor arthralgias
Thursday, Dec. 12 at 7:30 a.m. CT, a 3rd press conference hosted by Carlos L. Arteaga, M.D., president-elect of the AACR and associate director for ...
Oncoletter
Role of Aromatase Inhibitor in Endometriosis JASR 2018 82 73 85
Role of Aromatase Inhibitor in Endometriosis.
Research Media
Metastatic Breast Cancer Forum 2018: ER+ Breast Cancer | Dana-Farber Cancer Institute
At the 2018 Metastatic Breast Cancer Forum, Erica L. Mayer, MD, MPH, and Nikhil Wagle, MD, discuss research advances in the treatment of ER+ Breast Cancer ...
Dana-Farber Cancer Institute
Endocrine therapy in premenopausal women with HR+ breast cancer
Michael Gnant, MD, Vienna General Hospital, Vienna, Austria, discusses the management of endocrine therapy in premenopausal women with hormone ...
VJOncology
Emerging Research & Trials - Akashi [PPMD's 2016 Connect Conference]
Diana Escolar, MD from Akashi presents at PPMD's 2016 Connect Conference on June 28, 2016.
Parent Project Muscular Dystrophy
Age Management Medicine Interview "The Testosterone Syndrome" with Eugene Shippen, M.D.
Eugene Shippen, M.D. Author, “The Testosterone Syndrome” Interview Topic: Estrogen in Men AMMG Interviewer: Dr. Derrick DeSilva, Jr. Dr. Eugene Shippen ...
AMMG - CME Conferences & Certification
2018 Oncofertility Conference: Jennifer Levine, MD
Fertility Preservation Guidelines.
Oncofertility Consortium
Low-dose tamoxifen as effective as higher doses for breast cancer patients
Prof Andrea De Censi speaks to ecancer at SABCS 2018 about the results of the phase III TAM-01 clinical trial, where low-dose tamoxifen was found to be safe ...
ecancer
Breast cancer prevention in high-risk post-menopausal women
Prof Jack Cuzick gives a press conference at the 2019 San Antonio Breast Cancer Symposium about the preventative effects seen with anastrozole in ...
ecancer
James Ingle:
Webcast from 13th St. Gallen International Breast Cancer Conference 13-16 March 2013: Postmenopausal women with hormone receptor-positive breast ...
Oncoletter
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases
Visit http://www.ecancer.org for more. At a press conference at SABCS 2014, Dr Prudence Francis (Peter MacCallum Cancer Centre, Melbourne, Australia) ...
ecancer
Papel de inibidor de CDK4/6 associado a fulvestranto - ASCO 2018
Fulvestranto com Ribociclibe atingiu resultados muito semelhantes à associação de outros inibidores de CDK com inibidores de aromatase. Abemaciclibe com ...
Hospital Israelita Albert Einstein
A Nurse-led Approach to Osteoporosis Management - Jane Bollen
APNA 2019 National Conference - Building on the Best The Australian Primary Health Care Nurses Association's 11th annual conference for nurses working in ...
apnanurses
Analyzing ASCO 2016: Developments, takeaways, and implications from the conference
Every year the Informa Pharma Intelligence experts analyze the finding that come out during the ASCO annual conference. This year we are delighted to have ...
Pharma intelligence | informa
MedEClasses Grand Rounds Gynecomastia
Learn about the What, Why and How of Gynecomastia in the background of this interesting case of Gynecomastia.
Dr Anurag Bajpai
Plant-Based Nutrition: Powerful & Simple
Dr. Joel Fuhrman delivers a powerful talk on the subject of food addiction and emotional overeating. Filmed last year at the Plant Based World Conference ...
PLANT BASED NEWS
Living Beyond Breast Cancer: Metastatic Breast Cancer, Today's Research, Tomorrow's Treatments
Learn about clinical trials that will develop new pathways and strategies to treat and manage metastatic breast cancer tomorrow. Carey Anders, MD, lead this ...
Living Beyond Breast Cancer
Polycystic Ovarian Diseases: Basics & Updates | Dream Team Live Session by Dr. Prassan Vij
Watch Dr. Prassan Vij, discuss the basics and updates of Polycystic Ovarian Diseases. Comment your questions below or ask him during the live session using ...
PrepLadder
2020 EMBRACE Metastatic Breast Cancer Virtual Forum Series | Research Update for ER-Positive MBC
Daniel Abravanel, MD, PhD; Otto Metzger, MD; and Adrienne (Ada) Waks, MD; discuss advances in research and treatment for patients with ER-positive ...
Dana-Farber Cancer Institute
Low-dose tamoxifen reduces recurrence and new breast disease
Prof Andrea De Censi gives a press conference at SABCS 2018 about the results of the phase III TAM-01 clinical trial, where low-dose tamoxifen was found to ...
ecancer
Mayo Clinic Endoxifen Study
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor ...
Mayo Clinic
Advancing Targeted Treatment for Breast Cancer | Carola Neumann, MD | TEDxPittsburgh
Dr. Carola Neumann discusses how the latest findings in breast cancer research are helping to increase treatment options and what patients can do to empower ...
TEDx Talks
2015 MSK Alumni Conference - Vicky Makker, MD
"Targeted Therapy for Treatment of Advanced/Recurrent Endometrial Cancer"
Memorial Sloan Kettering Alumni Society
Fulvestrant improves survival over anastrozole for patients with advanced breast cancer
Visit http://www.ecancer.org for more. At a press conference at SABCS 2014, Prof Robertson (Royal Derby Hospital, Derby, UK) discusses the results of the ...
ecancer
Jun Mao (Speaker 3): Joint Conference, Acupuncture, Oncology & Fascia
Acupuncture for Cancer Pain: Jun Mao, MD, MSCE, Associate Professor, Perelman School of Medicine, University of Pennsylvania, PA. For more videos from ...
Aterah Nusrat
Dr. Angela Brodie remarks; development of aromatase inhibitors
Breast Cancer Research Foundation
Demystifying Breast Cancer
Survey link for registration is: https://cutt.ly/CFPCWebSep29 From screening recommendations, to diagnosis, to treatment and survivorship care, this talk aims to ...
CFPCMedia
